Hyperglycosylated human coagulation factor IX
The invention relates to hyperglycosylated human coagulation factor IX polypeptides, to processes for preparing said polypeptides, to pharmaceutical compositions comprising said polypeptides and to the use of the compounds for the treatment of diseases alleviated by human coagulation factor IX, in p...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
16.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to hyperglycosylated human coagulation factor IX polypeptides, to processes for preparing said polypeptides, to pharmaceutical compositions comprising said polypeptides and to the use of the compounds for the treatment of diseases alleviated by human coagulation factor IX, in particular, but not exclusively hemophilia. |
---|---|
Bibliography: | Application Number: EP20110172804 |